DRUG vs. NVDA
Compare and contrast key facts about Bright Minds Biosciences Inc (DRUG) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DRUG or NVDA.
Correlation
The correlation between DRUG and NVDA is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DRUG vs. NVDA - Performance Comparison
Loading data...
Key characteristics
DRUG:
1.97
NVDA:
0.79
DRUG:
25.97
NVDA:
1.32
DRUG:
4.11
NVDA:
1.17
DRUG:
29.16
NVDA:
1.17
DRUG:
103.03
NVDA:
2.89
DRUG:
27.65%
NVDA:
14.99%
DRUG:
1,464.42%
NVDA:
59.98%
DRUG:
-97.67%
NVDA:
-89.72%
DRUG:
-42.64%
NVDA:
-9.27%
Fundamentals
DRUG:
$232.45M
NVDA:
$3.30T
DRUG:
-$0.14
NVDA:
$2.94
DRUG:
0.00
NVDA:
25.30
DRUG:
5.62
NVDA:
41.63
DRUG:
$0.00
NVDA:
$104.45B
DRUG:
-$18.11K
NVDA:
$77.45B
DRUG:
-$2.12M
NVDA:
$68.38B
Returns By Period
In the year-to-date period, DRUG achieves a -11.19% return, which is significantly lower than NVDA's 0.96% return.
DRUG
-11.19%
-3.38%
-12.19%
2,808.18%
92.64%
N/A
N/A
NVDA
0.96%
33.58%
-3.25%
46.64%
101.11%
72.26%
74.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DRUG vs. NVDA — Risk-Adjusted Performance Rank
DRUG
NVDA
DRUG vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
DRUG vs. NVDA - Dividend Comparison
DRUG has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.03%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRUG Bright Minds Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.03% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
DRUG vs. NVDA - Drawdown Comparison
The maximum DRUG drawdown since its inception was -97.67%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for DRUG and NVDA. For additional features, visit the drawdowns tool.
Loading data...
Volatility
DRUG vs. NVDA - Volatility Comparison
Bright Minds Biosciences Inc (DRUG) has a higher volatility of 15.77% compared to NVIDIA Corporation (NVDA) at 11.79%. This indicates that DRUG's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
DRUG vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Bright Minds Biosciences Inc and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities